Senores Pharmaceuticals Limited
Read Time:15 Second
Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled “Senores Pharmaceuticals, Inc. announces the approval and launch of Deferiprone Tablets USP, 500 mg & 1000 mg which will be marketed by Dr. Reddy s Laboratories Inc. in the US market”. |SUBJECT: Press Release
Happy
0
0 %
Sad
0
0 %
Excited
0
0 %
Sleepy
0
0 %
Angry
0
0 %
Surprise
0
0 %
More Stories
Godrej Properties Limited
Godrej Properties Limited has informed the Exchange regarding a press release dated Jun 01, 2026, titled "Press Release". |SUBJECT: Press...
The Federal Bank Limited
The Federal Bank Limited has informed the Exchange regarding Allotment of Securities |SUBJECT: Alteration Of Capital and Fund Raising-XBRL
JINDAL STEEL LIMITED
JINDAL STEEL LIMITED has informed the Exchange about Schedule of meet |SUBJECT: Analysts/Institutional Investor Meet/Con. Call Updates
E Factor Experiences Limited
E Factor Experiences Limited has informed the Exchange about Investor Presentation |SUBJECT: Investor Presentation
Ahlada Engineers Limited
Ahlada Engineers Limited has informed the Exchange regarding Outcome of Board Meeting held on May 30, 2026. |SUBJECT: Outcome of...
Krishca Strapping Solutions Limited
KRISHCA STRAPPING SOLUTIONS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Average Rating